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Abstract. Work from several laboratories has 
identified a proteoglyean complex secreted by a  variety 
of non-neuronal cells that can promote neurite 
regeneration when applied to the surface of culture 
dishes.  Using a novel immunization protocol, a 
monoclonal antibody (INO) was produced that blocks 
the activity of this outgrowth-promoting factor (Mat- 
thew, W.  D.,  and P.  H.  Patterson,  1983, Cold Spring 
Harbor Symp. Quant. Biol. 48:625-631).  We have 
used the antibody to analyze the components of the 
active site and to localize the complex in vivo. INO 
binding is lost when the complex is dissociated; if its 
components are selectively reassociated, INO binds 
only to a  complex containing two different molecular 
weight species. These are likely to be laminin and hepa- 
ran sulfate proteoglycan, respectively. On frozen 
sections of adult rat tissues, INO binding is present on 
the surfaces of glial cells of the peripheral, but not the 
central, nervous system. INO also binds to the base- 
ment membrane surrounding cardiac and skeletal mus- 
cle cells, and binding to the latter greatly increases af- 
ter denervation. In the adrenal gland and kidney, INO 
selectively reacts with areas rich in basement mem- 
branes,  staining a  subset of structures that are im- 
munoreactive for both laminin and heparan sulfate 
proteoglycan. In general, the outgrowth-blocking anti- 
body binds to areas known to promote axonal regener- 
ation and is absent from areas known to lack this abil- 
ity. This suggests that this complex, which is active in 
culture, may be the physiological substrate supporting 
nerve regeneration in vivo. 
oNs  damaged  in  the  peripheral  nervous  system 
(PNS) 1 of  adult  mammals  have  the  capacity  to 
regenerate over long distances. The prerequisites for 
successful neurite outgrowth include the presence of trophic 
factors, such as nerve growth factor (3), and/or an appropri- 
ate surface on which to grow (30).  The molecular nature of 
the surfaces that allow or stimulate regeneration in vivo is 
not known. Experiments in culture, however, have delineated 
a number of candidate molecules that can promote neurite 
outgrowth under specific conditions. For instance, surfaces 
coated with laminin or fibronectin stimulate a much more 
rapid and extensive regeneration of neuronal processes than 
can serum- or collagen-coated plastic (2, 4, 9, 24, 29, 31, 39, 
44). The finding that laminin, in particular, provides an espe- 
cially good substrate for outgrowth is of interest because a 
variety  of  non-neuronal  cells  secrete  neurite  regenera- 
tion-promoting factors (1, 12, 14, 26), some of which are ex- 
tracellular matrix complexes containing primarily laminin 
and heparan sulfate proteoglycan (HeSPG) (8,  16, 28). 
Since laminin is a  component of a  naturally occurring, 
1. Abbreviations  used in this paper: CM, conditioned medium; CNS, cen- 
tral nervous system; DRG, dorsal root ganglion; HeSPG,  heparan sulfate 
proteoglycan; PNS, peripheral nervous system. 
neurite-promoting complex, and purified laminin can stimu- 
late outgrowth in culture, the question arises as to whether 
there is a role for the HeSPG component of the outgrowth 
factor. The complexity of the problem is indicated by the ob- 
servation that antibodies that block the outgrowth-promoting 
effect of purified laminin do not usually block the effect of 
the natural complex (17, 27, 31). It is important, therefore, to 
understand the nature of the active site in the complex that 
stimulates neurite regeneration. To obtain information on the 
molecules that contribute to the active site, and to localize 
it in vivo, monoclonal antibodies were isolated that directly 
block the outgrowth-promoting activity of the complex (34). 
These antibodies were generated by a novel immunization 
procedure  designed  to  produce  monoclonal  antibodies 
against rare antigens. The binding of one of these antibodies, 
INO  (inhibitor of neurite outgrowth), to the complex re- 
quires the association of both laminin and HeSPG. We have 
also used this antibody to study the distribution of this epi- 
tope in vivo. The INO-binding site is found in areas known 
to promote axonal regeneration in vivo, and is not detected 
in areas where regeneration does not occur. These findings 
raise the possibility that the failure of central nervous system 
(CNS) axons to regenerate over long distances may be ex- 
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complex. 
Materials and Methods 
Cell Culture and Conditioned Media 
PCI2 cells were maintained in L15 CO2 medium (23), supplemented with 
10%  fetal calf serum and 5%  heat-inactivated horse serum.  Cells were 
grown in medium containing nerve growth factor and serum for 2 wk, then 
in serum-free  medium for 12 h, rinsed, and fresh serum-free medium added. 
After 3 d, 500 ml of conditioned medium (CM) was collected and adsorbed 
to a  20-ml column of DEAE cellulose equilibrated with 150 mM NaCI 
and 10 mM phosphate (pH 7). The column was washed with 150 mM NaCI 
and the neurite outgrowth activity and HeSPG were eluted with 1.5 NaC1 
and stored at  -20  °  . 
A non-neuronal, fibroblast-like line established from primary dorsal root 
ganglion (DRG) cultures (33),  secretes a  high concentration of neurite- 
promoting activity.  Cells were grown to confluence in L15C(h medium 
containing 10% fetal calf serum, then in serum-fr~ medium for 2 d, rinsed, 
and maintained in a serum-free medium until the medium began to turn 
acidic (4-8 d). The final collection of 500 ml CM was then fractionated on 
DEAE cellulose as described above. 
Fractionation of 35S-Labeled Medium 
The DRG non-neuronal cell line was grown to confluence in 75-cm  2 flasks 
in LI5 CO2 medium containing 10% fetal calf serum and then maintained 
for 2 wk in serum-free L15 CO2 medium. Cultures were briefly rinsed in 
sulfate-free L15 CO2 and each flask was incubated in 10 ml of medium con- 
raining 1 mCi of carrier-free [35S]sulfate (ICN Biomedicals Inc., Irvine, 
CA). After 7 d, the CM was removed, stored on ice, and experiments were 
completed within 6 d. Approximately 1% of the radioactivity was excluded 
from Sephadex (325. 
5 ml of labeled CM was incubated with 0.5 ml of DEAE (equilibrated 
with 0.15 M NaCI) for 30 min at room temperature. The DEAE was packed 
into a column and washed extensively with Hanks buffer (Gibeo, Grand Is- 
land, NY) followed by 5 ml of calcium-magnesium-free Hanks buffer. The 
INO antigen was eluted with concentrated caicium-magnesium-free Hanks 
buffer (0.5  M  NaC1).  Fractions were collected, an aliquot of each was 
counted for 35S, and appropriate samples were pooled. Where noted, solid 
guanidine HCI was added to bring an aliquot to a concentration of 6 M. 
These samples were stored overnight on ice before being chromatographed 
on a  1 cm  ×  26 cm column of Sepharose 4B.  This column was either 
equilibrated with 0.15 M NaC1 or 6 M guanidine. Single drops (50-1~1 each) 
were collected into individual wells of flexible microtiter dishes. Sequential 
samples were assayed with either a solid phase radioimmunoassay (25, 32) 
for binding of the INO antibody, pg42, or a control monoclonal antibody 
(SV 48) that recognizes a synaptic vesicle antigen and does not bind to CM, 
or counted for 35S radioactivity. In those cases where samples contained 
guanidine, fractions were first pooled and then desalted on Sephadex (325 
columns. Each value cited is the average of two samples. The void volume 
and the total volume for this column was determined using Blue Dextran 
and 35S. 
Antibodies 
Monoclonai IgG antibodies C21 and C24, which recognize laminin (20); 
pg22, pg42 (33), and C17 (18), which bind to HeSPG; and monoclonal IgM 
antibody INO were obtained as previously described (33, 34, 42). Rabbit 
anti-rat N-CAM was provided by J. R. Sanas and J. Covault (Washington 
University, St.  Louis, MO);  rabbit anti-chicken neurnfilament antibody 
(anti-NF160)  was a gift of E. Lazarides (California Institute of Technology, 
Pasadena, CA). Rabbit anti-Po was supplied by G.  Lemke (Saik Institute, 
La Jolla, CA) and J. Brockes (Medical Research Council, Cambridge, En- 
gland); rabbit anti-mouse laminin antibody was purchased from Bethesda 
Research Laboratories (Gaithersburg, MD). 
For  the precipitation and  competition assays,  goat  anti-mouse IgG, 
heavy- and light-cbain specific, was obtained from Boehringer Mannheim 
Biocbemicals (Indianapolis, IN); biotinylated anti-mouse IgM, mu-chain 
specific, as well as avidin peroxidase, were supplied by Vector Laboratories 
(Burlingame, CA). For the immunofluorescence studies, high fluorescein- 
conjugated goat anti-mouse Ig was purchased from Antibodies Inc. (Davis, 
CA); rhodamine-conjugated goat anti-rabbit Ig was obtained from Cappel 
Laboratories (West Chester, PA). Biotinylated goat anti-mouse IgM and 
fluoresceiuated strepavidin were purchased from Cappel Laboratories and 
Bethesda Research Laboratories, respectively. 
Precipitation Assay 
Mouse ascites fluids, all containing at least 1 mg/ml monoclonai IgG anti- 
body (pg22, pg42, C17, C21, C24), were diluted 1:200 in 100 mM Tris, (pH 
7.2).  Normal mouse serum and rabbit anti-mouse laminin serum (Bethesda 
Research Laboratories) were also used at  1:200 dilutions. All operations 
were carded out at room temperature.  Individual wells of 96-well fiat- 
bottom,  Immunolon  1  plates  (Dyuatech  Laboratories,  Inc.,  Dynatech 
Corp., Alexandria, VA) were incubated with 40 ttl of diluted antibody for 
30 rain, then incubated with 2% BSA in 100 mM Tris buffer for 10 rain fol- 
lowed by four washes with Tris buffer.  Washing consisted of adding 100 I.tl 
of  buffer to each well, emptying the plate by inversion, and blotting on paper 
towels. Wells were next incubated for  1 h  with fresh L15 CO2 medium 
(control) or with serum-containing CM from either the DR(; cell line or 
PC12 cells. The wells were washed four times and then incubated with 50 
ttl of fresh INO hyhridoma medium for 2 h, followed again by four washes. 
The wells were incubated with 50 ttl of 1% BSA containing 20 ttg/nd goat 
anti-mouse IgG for 30 rain to help prevent cross reaction with subsequent 
anti-mouse IgM and the ascites IgG. Without washing, 50 ttl of  biotinylated 
anti-mouse IgM (10 ~tg/ml) antiserum was added for a 2-h incubation. The 
wells were washed four times before adding 100 ~tl of avidin-peroxidase re- 
agent for 1 h. After washing, peroxidase was reacted with diaminobenzidine 
and 0.03 % peroxide in Tris. The reaction was stopped after 5 rain by addi- 
tion of 50 ttl of 1% HCI and the reaction product was measured as OD at 
405 tun. 
Competition Assay 
Wells were coated with 100 ttl of serially diluted, serum-free CM from ei- 
ther the DRG or PC12 cell line. A serial dilution of INO culture fluid in 
1% BSA-Tris buffer (pH 7.2) was also bound to the wells to determine the 
appropriate concentrations of CM  and INO  culture fluid such that the 
amount of INO antibody would be limiting in each assay. A  1:150 dilution 
of INO culture fluid was found to give a  signal of 65 % of the maximum 
signal for a 1:4 dilution of PC12 CM, and 80 % of  maximal signal for a 1:256 
dilution of DRG cell CM. All subsequent assays used the same stock of CM 
(1:4 for PC12 and 1:256 for DRG cells) and a stock of 1:15 dilution of INO 
culture medium stored at 4°C for not more than 3 d. 
Immunolon wells were coated with fresh L15 CO2 medium (control) or 
with either DRG or PC12 cell CM for 30 rain and washed. Wells were then 
incubated for 1 h at room temperature with 50 gl of competing antibody: 
ascites fluids were all used at >1 mg/ml monoclonal IgG antibody while nor- 
mal mouse serum and rabbit anti-mouse laminin serum were diluted 1:200 
with 2% BSA-Tris. Without washing, 50 gl of a 1:75 dilution of INO culture 
fluid was added to each well and co-incubated for 1 h before washing. The 
specific binding of mouse IgM (INO) was subsequently quantified as de- 
scribed for the precipitation assay. 
Immunohistochemistry 
Freshly dissected, unfixed rat tissues were mounted on metal chucks with 
gum tragacanth (Eastman Kodak Co., Rochester, NY) and flash frozen in 
liquid nitrogen-cooled isopentane. For direct comparisons of staining pat- 
terns and intensities, several tissue types were assembled, frozen, sectioned, 
stained,  and photographed together. Sections (4-10  ttm) were cut on a 
cryostat (Hacker Instruments Inc.,  Fairfield, N J),  air dried on ethanol- 
cleaned glass slides and stored frozen until used. 
After a 10-min preincubation at room temperature in PBS containing 10 
mg/ml BSA (PBS-BSA), sections were incubated overnight with primary 
antibody at 4°C in a humidified chamber. INO hybridoma medium was used 
undiluted; C17, C21, and C24 ascites fluids were diluted to 1:250. In double- 
label experiments, sections were co-incubated with a mouse monoclonal 
and  a  rabbit  antiserum.  Anti-N-CAM  was  used  at  a  1:200  dilution; 
anti-NF160 and anti-Po were diluted to 1:100. All dilutions were made with 
PBS-BSA. Excess primary antibodies were removed by rinsing the slides 
thrice with PBS (10 min each), and nonspeciflc binding sites were blocked 
with a  10-rain incubation in PBS-BSA containing 10% normal goat serum 
before applying marker-conjugated secondary antibodies. 
Because mouse and rat immunoglobniins share many determinants, sec- 
ondary antibodies against mouse immunoglobulins were diluted and preab- 
sorbed with PBS-BSA containing 10%  normal rat serum for 1 h at room 
temperature, and centrifuged in an Eppendorf microfuge for 10 rain before 
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re~gnize rat determinants on the sections, significantly reducing back- 
ground staining by secondary antibodies. Fluoresceinated goat anti-mouse 
Ig(l:100 dilution) was used to visualize C17, C21, and C24 binding; rhodami- 
hated anti-rabbit Ig (1:100) revealed binding by antisera. To view INO im- 
munoreactivity, a sandwich consisting of biotinylated goat anti-mouse IgM 
(1:75 dilution) followed by fluorescein-strepavidin (1:50) was used. Sections 
were incubated with secondary and then tertiary reagents for 1 h each at 
room temperature before mounting with glycerol-phenylenediamine (46) 
for viewing. To identify nuclei, a final pulse (5-10 s) of 10 ttg/ml propidium 
iodide was applied and rinsed  jnst before mounting. Propidium iodide binds 
to nucleic acids and can be viewed with filters for rhodamine. 
Endplate-bearing sections (2  ttm) of diaphragm were obtained as de- 
scribed by Sanes and Hall (41) and synaptic sites identified by co-incubation 
with  rhodaminated-ct-bungarotoxin (38),  which  binds  to  acetylcholine 
receptors on the postsynaptic membrane. For studies on denervated muscle, 
the left phrenic nerve of adult (>150  g) female rats was cut under ether 
anesthesia, and a 2-4-mm segment removed to prevent reirmervation. After 
appropriate intervals (4 d to 4.5 wk), the animals were sacrificed. Dener- 
vated diaphragm was sandwiched between pieces of  the contralateral, inner- 
vated control hemidiaphragm and  sectioned for imrnunohistoehemistry. 
Empty sheathes of muscle basal lamina were obtained by surgically induc- 
ing degeneration of intercostal myofibers (39); 3--4 d later the damaged tis- 
sue was dissected and sectioned. 
Results 
Composition of  the INO-binding Site 
The source for the neurite-promoting activity used in this 
study was a non-neuronal cell line isolated from a primary 
culture of newborn rat DRG cells (33). This line secretes a 
high  level  of  the  INO  antigen  as  well  as  the  neurite- 
promoting activity. Five monoclonal antibodies that recog- 
nize determinants on HeSPG and precipitate the  neurite- 
promoting activity in CM, bind to the surface of these cells 
in culture (33).  These DRG-derived cells were incubated 
with 35S-labeled  sulfate,  a  procedure that primarily labels 
proteoglycans (22, 35). The INO antigen was coeluted from 
DEAE cellulose between 0.3  and 0.5  M  NaCI and chro- 
matographed on Sepharose 4B. Both the pg42 (a monoclonal 
antibody that binds the core protein of HeSPG [33] and can 
precipitate the neurite promoting activity but not block it 
directly) and INO immunoreactivity coeluted with most of 
the 35S-labeled material, which had an apparent molecular 
mass of "ol07 D  (Fig.  1).  Thus neurite-promoting activity, 
as identified by INO binding, is associated with a HeSPG. 
To determine whether the INO-binding site is part of the 
HeSPG itself or is associated with a complex of HeSPG with 
another molecule, the sulfate-labeled DEAE fraction was 
dissociated  in  6  M  guanidine  and  chromatographed  on 
Sepharose 4B equilibrated with 6 M guanidine (Fig. 2). Sul- 
fate label and HeSPG antigen (as measured by pg42 binding) 
migrated with a molecular mass of ,o300 kD. No INO bind- 
ing  could  be  detected  after guanidine  removal  (Fig.  2). 
Therefore, either the antigen was destroyed by guanidine or 
the determinant results from the association of several differ- 
ent molecules. 
The latter possibility was tested in a reassociation experi- 
ment. CM was fractionated in guanidine over a Sepharose 
column as before, and fractions were pooled into four large 
groups (Fig. 3). Only one fraction, C, contained HeSPG (Ta- 
ble I). The four fractions were recombined in all combina- 
tions of two, the guanidine removed, and each combination 
was tested for INO antigenicity, Most of  the INO binding was 
obtained by mixing the HeSPG fraction with a high molecu- 
lar weight fraction that does not contain a significant amount 
of sulfate label or HeSPG antigen, but which very likely does 
contain laminin because of laminin's  very high molecular 
weight (Table I). 
These results suggested that the INO epitope is associated 
with  HeSPG  and  laminin.  In  fact,  several  groups  have 
provided convincing evidence that the outgrowth-promoting 
activity is associated with a  HeSPG-laminin complex (16, 
28). To confirm that this was also true in the CM used in the 
present study, several monoclonal and polyclonal antibodies 
to laminin and HeSPG were tested for their ability to precipi- 
tate the INO determinant from the DRG cell line CM and 
PC12 cell CM (Table ID. Both sets of antibodies were able 
to precipitate significant amounts of INO antigen, whereas 
a control antibody, SV48,  did not. 
As an additional test for the contribution of laminin and 
HeSPG to the INO determinant, monoclonal and polyclonal 
antibodies against laminin and HeSPG were used to compete 
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Figure 1.  Sepharose 4B column fraction- 
ation,  under  native conditions,  of 35S-la- 
beled CM from a DRG non-neuronal cell 
line• Labeled  medium  was  prepared  and 
fractionated as described in Materials and 
Methods. Fractions were analyzed for 35S 
radioactivity (n), and assayed for the pres- 
ence of INO (e) and HeSPG (o) immuno- 
reactivity, using  the  INO and  pg42 anti- 
bodies, respectively. Kay, (elution volume 
-  void volume)  +  (total volume  -  void 
volume). 
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Figure 2.  Sepharose 4B column  fraction- 
ation, under denaturing conditions, of DRG 
cell CM. Labeled CM was prepared as de- 
scribed in Materials and Methods, adjusted 
to 6 M guanidine, and fractionated in 6 M 
guanidine. Every third fraction was counted 
for radioactivity to determine the glycosa- 
minoglycan profile. Pools A-H were made 
from the remaining fractions, desalted, and 
assayed  for  immunoreactivity  with  the 
pg 42 and INO antibodies.  Fractions were 
analyzed for 3sS radioactivity (D), and as- 
sayed  for  the  presence  of INO  (e)  and 
HeSPG  (0)  immunoreactivity,  using  the 
INO and pg42 antibodies, respectively. Kav, 
(elution volume  -  void volume)  +  (total 
volume  -  void volume). 
with the INO antibody for its binding site. It is clear that both 
sets of antibodies are able to effectively inhibit the INO anti- 
body in  its binding  to CM  from two  sources  (Table III). 
Therefore,  several lines  of evidence support the idea that 
INO binds to a high molecular weight acidic complex made 
up of at least two molecules, most likely laminin and HeSPG. 
It is interesting that the HeSPG antibodies were generally 
better than the laminin antibodies both at precipitating the 
INO-bearing  complex and  inhibiting  INO binding  to  the 
complex. 
Localization of  lNO Immunoreactivity in the 
Adult Rat Nervous System 
We used direct immunofluorescence to study the distribution 
of INO binding in the PNS and CNS of the adult rat. INO 
stained the surfaces of non-neuronal cells (Schwann cells and 
satellite cells) in all parts of the PNS examined. Within the 
DRG and the superior cervical ganglion, INO binds to the 
basement membrane of satellite cells that ensheaths neuronal 
cell bodies and processes (Figs. 4 and 5). Non-neuronal cells 
elaborate an extensive extracellular matrix within peripheral 
ganglia,  especially the  SCG;  the  pattern  of INO staining 
strongly resembles patterns seen with antibodies to known 
matrix components including laminin (using C21  and C24) 
and HeSPG (using C17). In the sciatic nerve, a mixed periph- 
eral nerve trunk, INO binds to the outer or abaxonal surface 
of both myelinating and unmyelinating Schwann  cells,  al- 
though the antibody appears to stain the sheath around un- 
Table L Reconstitution  of the INO Determinant 
from Guanidine Extracts 
pg 42 in radio-  INO in radio- 
Fraction  immunoassay  irnmunoassay 
cpm  cpm 
A  136  122 
B  174  199 
C  5,877  136 
D  161  85 
A+B  150  246 
A+C  4,992  190 
A+D  123  150 
B+C  3,281  1,869 
B+D  145  427 
C+D  4,048  311 
A  B  C  D 
o 
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Figure 3. Sepharose fractionation of CM under denaturing condi- 
tions for a reassociation experiment.  CM was produced and frac- 
tionated as described  for Fig.  2 except that  fractions A-D were 
pooled as shown. 
Table IL Monoclonal and Polyclonal Antibodies to Laminin 
and HeSPG Can Precipitate the INO Antigen 
Precipitating antibody  DRG cell CM  PCI2 cell CM 
OD¢o~ x 10  J  OD4osX 103 
HeS pg22  2,397  1,913 
HeS pg42  2,447  1,926 
HeS C17  1,080  530 
Lam C21  1,437  624 
Lam C24  1,180  642 
Anti-laminin  t,786  1,192 
SV 48  7  38 
Precipitating antibodies were absorbed to 96-well immunoplates, which were 
then washed and incubate~d with CM. After washing, INO antibody was in- 
cubated and  immunoreactivity was  detected using an  enzyme-linked im- 
munosorbent assay. 
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to Laminin and HeSPG Can Compete with the INO 
Antibody  for Binding to CM 
DRG cell CM  PCI2 cell CM 
Competing antibody  (% inhibition)  (%  inhibition) 
BSA control  0  0 
HeS pg22  81  90 
HeS pg42  85  90 
HeS  C17  46  49 
Lain C2l  10  22 
Lam C24  11  23 
Anti-laminin  82  79 
SV 48  3  14 
CM were absorbed to 96-well immunoplates, which were then washed and in- 
cubated with competing antibodies. A limiting amount of INO antibody was 
added and INO immunoreactivity was detected  using an enzyme-linked immu- 
nosorbent assay. 
myelinated fibers much more brightly (Fig. 6). Double-label 
experiments, using INO and anti-NFl60 to mark the location 
of  axons,  demonstrate  that  the  side  of  the  ensheathing 
Schwann  cell  that  faces  axonal  surfaces  is  devoid  of im- 
munoreactivity, as is the axon.  Because only the abaxonal 
Schwann cell surface is known to organize and accumulate 
a basement membrane, this asymmetry in INO immunoreac- 
tivity supports the notion that the antibody recognizes a com- 
ponent within the basement membrane or the extracellular 
matrix of the  endoneurium.  The mAb's to HeSPG and to 
laminin (C17, C21, and C24) similarly stain the endoneurium 
in peripheral nerves (18, 42). 
Unlike C17 and C24, INO and C21 do not stain the loose 
connective tissue, or epineurium, which surrounds periph- 
eral ganglia (Fig. 5) and major nerve trunks. INO, C17, and 
C24, but not C21,  also bind to the perineurium that groups 
fasicles  of nerves  and  forms  the  outer  connective  tissue 
sheath around small intramuscular nerves when they split off 
from major nerve trunks  (Fig.  7).  INO immnnoreactivity 
continues  down  nerves  to  their  terminal  arborizations  in 
muscle. 
Figure 4. Endoneurium  in adult rat DRG bears INO, laminin,  and HeSPG determinants.  Antigens recognized by C17 (a), C24 (b), and 
INO (c) are present on the surface of satellite cells (s), some of which cluster along the periphery of the sensory neurons (N). The INO- 
stained section (c) was double-labeled with propidium iodide (d) to reveal nuclei of neurons and satellite cells. Whereas INO clearly stains 
a unique epitope in neuronal nuclei,  antibody binding is not detectable in nuclei of satellite cells.  Bar, 50 Ixm. 
Chiu et al. Neurite Regeneration  Blocking Activity  1387 Figure 5. Immunohistochemical staining of 10-1~m sections of rat superior cervical ganglion reveals similar patterns of cell-surface staining 
with INO (a), C17 (b), C24 (c), and C21 (d). All four antibodies recognize components that appear abundant in the extracellular matrix 
on the surfaces of satellite cells ensheathing the neurons. Only INO stains neuronal nuclei (n in a). Whereas C17 and C24 also bind to 
the epineurium (arrow), INO and C21 do not. Bar, 50 I~m. 
Peri- and endoneurial staining by INO is present in both 
dorsal and ventral spinal roots; thus both proximal and distal 
projections of peripheral nerves maintain immunoreactivity. 
However, sections of spinal cord reveal that staining by INO, 
C17, C21, and C24 ceases at the transitional region (6) be- 
tween the PNS and the CNS (Figs. 8 and 9), and, except for 
the binding of capillary and meningeal surfaces, there is no 
detectable antibody binding within either grey or white mat- 
ter of the spinal cord. An exception is the binding of INO 
to neuronal nuclei, which is discussed below. Similarly, sec- 
tions of optic nerve and of olfactory bulb are devoid of stain- 
ing (not shown), whereas flanking sections of sciatic nerve 
are  highly  immunoreactive.  Because  blood  vessels  and 
meningeal membranes are the only places within the CNS 
where  an organized basement  membrane is  visible ultra- 
structurally, the absence of antibody binding is consistent 
with the  localization/restriction of INO-,  C17-, C21-, and 
C24-binding  sites to the extracellular matrix.  The restric- 
tion, therefore, of INO binding to the PNS may be a conse- 
quence of the  lack  of an  organized basement  membrane 
within the adult CNS. 
Distribution of  lNO Binding in Muscle and 
Other Basement Membranes 
The cell surface INO epitope is also present on surfaces of 
three muscle cell types examined. Sections of rat ventricle 
and diaphragm show that both cardiac and skeletal muscle 
fibers are stained by INO (Fig.  10 a). In sections of muscle 
spindles, INO binds to the capsule as well as to both bag and 
chain  intrafusal  fibers  (Fig.  10  b).  Immunoreactivity on 
skeletal muscle extends to the very ends of the fibers where 
The Journal of Cell Biology,  Volume 103, 1986  1388 Figure 6.  Sections of rat sciatic nerve stained with INO (a) and 
anti-NF 160 (b) show INO reactivity is restricted to the abaxonal 
surfaces of Schwann cells. The neurofilarnent-containlng profiles 
are clearly not in contact with the INO sites, both on myelinated 
and unmyelinated fibers. Only the abaxonal surface is stained by 
C17, C21, and C24 (data not shown) and bears a basal lamina. In 
the bright, triple-laminated profile (arrow), the axon appears to be 
enclosed by a myelinated sheath, which in torn has been wrapped 
by a second Schwarm cell. Thus the abaxonal basal lamina of the 
myelinating Schwann cell faces another Schwann cell and bears a 
basal lamina on both surfaces. Such profiles are rare. Bar, 50 txm. 
myotendinous  junctions are found to be brightly stained (not 
shown), When skeletal myofibers were damaged to generate 
empty basal lamina sheaths, INO staining persisted in these 
preparations and co-localized with profiles concommitantly 
stained with anti-laminin, which marked the empty tubes of 
basal lamina (Fig.  10, c and d). In skeletal muscle, INO is 
also presentat the neuromuscular junction where it co-lo- 
calizes with rhodamine-a-bungarotoxin, a marker for post- 
synaptic acetylcboline receptors (Fig. 10, e-h). Thus in mus- 
cle, as in nerve, INO appears to recognize an epitope present 
throughout the muscle basement membrane. 
Molecules that are involved in neuronal adhesion (15) or 
in the promotion of neurite outgrowth (21, 45) have been 
found to increase when muscles are denervated. To examine 
the effects of denervation on the amount or distribution of 
INO,  innervated  and  denervated  hemidiaphragms  were 
mounted in a single block and then sectioned, stained, and 
photographed together. As it is known that levels of N-CAM 
rise in denervated muscle, sections were doubly labeled with 
anti-N-CAM to confirm successful denervation. We found 
that a rise in INO immunoreactivity was detectable on the 
surfaces of  muscles after 1 wk ofdenervation; this difference 
in staining intensity between innervated and denervated mus- 
cles increased with time and was quite dramatic by 4.5 wk 
(Fig.  11). Although smaller, an increase was also detected 
with C17, the monoclonal antibody that recognizes HeSPG. 
However, no difference between innervated and denervated 
muscle  was  detectable  when  consecutive  sections  were 
reacted with C21, C24, or polyclonal antibodies to laminin, 
which suggests that the increase in INO and C17 staining in- 
tensity is not merely due to a general increase in basal lam- 
ina, or to muscle atrophy. Similar results were reported by 
Sanes and co-workers (43),  who, using antibodies against 
laminin and fibronectin, also detected no change in the stain- 
ing of basal lamina of muscle after denervation. However, 
in contrast to our results with C17, they did not see any con- 
sistent  increase  in ,levels of HeSPG upon denervation.  If 
suprathreshold levels of primary and secondary antibodies 
were used in these comparative studies, such differences in 
staining intensity may be less apparent. We find a specific 
rise in the INO epitope concurrent with an increase in C17 
binding,  in the apparent absence of any change in laminin 
content or distribution, when muscles are denervated. 
In both muscle and nerve, INO binds to areas rich in base- 
ment  membranes;  however not  all  basement  membranes 
bear this epitope. We analyzed INO binding in two other tis- 
sues known to be rich in extracellular matrix components 
(Table IV). Within the adult rat adrenal gland, INO binds to 
connective tissue that surrounds groups of chromatlin cells 
in the adrenal medulla. Double-staining with anti-NF160 in- 
dicated that large bundles of innervating sympathetic axons 
travel  along  these  corridors  of extracellular  matrix  (not 
shown). Staining was absent in the adrenal cortex. This dis- 
tribution precisely matches that of laminin; however HeSPG 
is  present  in  both  medullary  and  cortical  areas  of  the 
adrenals. The kidney, a tissue rich in basement membranes, 
was heavily invested with HeSPG and laminin.  INO, how- 
ever, shows a very restricted distribution and could be de- 
tected only on the glomerular capsule.  Similarly, INO did 
not bind to major blood vessels, which bear a basal lamina 
rich in HeSPG and laminin (Fig.  7). 
In summary, INO binds to basal lamina-rich regions in 
Chiu et al. Neurite Regeneration  Blocking Activity  1389 Figure 7.  Consecutive sections of rat diaphragm,  stained with INO (a), C21 (b), C17 (c), anti-laminin (d), and C24 (e) demonstrate that 
INO binds to a subset of basement membranes that bear both HeSPG and laminin antigens. Four types of basement membranes are present 
in each field: skeletal muscle basal lamina (M), blood vessel basal lamina (BV), endoneurium (EAr), and perineurium (PN) of intramuscular 
nerves. Anti-laminin, C17, and C24 stain all four types of  basement membranes; INO immunoreactivity is present in all except blood vessels. 
C21, which recognizes a more restricted laminin epitope, is absent in both blood vessels and perineurium. Thus, not all laminin epitopes 
are present or available for binding in laminin-bearing matrices, and INO binding is detectable in some but not all structures bearing both 
HeSPG and laminin.  (c and d) The same field double-labeled with C17 and anti-lamininfis the phase view of the field stained with C24 
in e.  Bar,  100  Ixm. 
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port neurite outgrowth. The enrichment of the INO epitope 
on denervated muscle raises the possibility that this epitope 
may be involved in the propensity of denervated muscle to 
promote neuronal sprouting and reinnervation. The distribu- 
tion of the INO epitope in other basement membranes is, 
however, much more restricted. Whereas all INO binding 
sites  in  the  extracellular matrix also  contain HeSPG and 
some form of laminin, not all basement membranes contain- 
ing both of these matrix components show INO immunore- 
activity.  The  manner of their association,  as  well  as  the 
specific isoforms of these two molecules (see Discussion), 
may determine whether the INO determinant is expressed. 
Thus, HeSPG and laminin appear to be necessary, but not 
sufficient, for the generation of the INO epitope in extracel- 
lular matrices. 
As reported previously (32), INO also recognizes an epi- 
tope in adult neuronal nuclei (Figs. 4, 5, and 9) and in nuclei 
undergoing active transcription, such as in liver, epithelia, 
spermatogonia  (but  not  sperm),  and  developing  (but  not 
adult) and regenerating muscles. While this is intriguing, it 
is unlikely that this epitope resides in the same complex as 
the  neurite-promoting  factor.  None  of our  antibodies  to 
HeSPG or to laminin bind to nuclei; thus if these molecules 
are found in the nucleus (19), they must be different from 
those in the extracellular matrix. Although monoclonal anti- 
bodies are described as monospecific in that they recognize 
a  very defined determinant,  they cannot discriminate  be- 
tween different molecules which happen to share the same 
epitope. It is therefore likely that the nuclear-binding site for 
INO  resides  in  a  molecule(s) different from the  neurite- 
promoting complex in the extracellular matrix. 
Discussion 
The ability of purified laminin to support and guide neurite 
regeneration in vitro has raised the possibility that the lami- 
nin component of  the native complex is solely responsible for 
the outgrowth activity in CM. This simple interpretation has 
been challenged by the observation that antibodies to lami- 
nin, which block laminin-induced outgrowth, fail to abrogate 
the activity of the naturally secreted factors (8,  15, 25, 29). 
Thus it is unclear what comprises the neurite-promoting site 
on the native complex, nor is it known what is the physiologi- 
cal  substrate  on  which  axons  regenerate  in  vivo.  Since 
the  monoclonal antibody INO  can directly block neurite 
regeneration stimulated by at least two naturally occurring 
factors (34), understanding the requirements for and the dis- 
tribution oflNO binding should yield information on the na- 
tive neurite-promoting site. 
INO appears to recognize an epitope generated by the as- 
sociation of  at least two components, most likely laminin and 
HeSPG. Polyclonal and monoclonal antibodies specific for 
laminin  or  for  HeSPG  selectively  precipitate  the  INO- 
bearing complex harvested from media conditioned by the 
DRG cell line and by PC12  cells.  Other investigators have 
also found that neurite-promoting factors released by a vari- 
ety of cells in culture, including chick skeletal muscle (8), 
rat Schwannomas (16), and bovine corneal endothelial cells 
(28),  consistently contain both laminin and HeSPG.  INO 
binding is lost when the complex is dissociated and fraction- 
ated into its components; however, immunoreactivity can be 
recovered upon selective reassociation of two of these frac- 
tions. This data shows that neurite-promoting activity of the 
natural.laminin-HeSPG complex is amenable to direct anti- 
body blockade only when its components are in association. 
These results raise the questions of how formation of the 
complex results in the generation of the INO-binding site, 
and why anti-laminin antibodies are unable to block the ac- 
tivity of the native complex. In studies of different binding 
domains on the laminin molecule, only antibodies directed 
against the major HeSPG-binding fragment are competent to 
block the neurite-promoting activity of laminin (17). This 
supports the idea that the neurite-promoting site on laminin, 
site A, is located at or near where HeSPG binds, and anti- 
laminin sera presumably block bioactivity by binding at or 
near this  site.  Formation of the HeSPG-laminin complex 
could have several possible outcomes. First, the proteogly- 
can may convert site A to a new active form, B, which is now 
recognized by INO but not by blocking anti-laminin antibod- 
ies. Heparan sulfates have been reported to induce confor- 
mational changes in fibronectin, another component of the 
extracellular  matrix  (36).  Alternatively,  association  with 
HeSPG may sterically hinder access of the relevant anti- 
laminin antibodies and at the same time create a new epitope, 
the INO-binding site, nearby so that INO binding now blocks 
the availability/activity of site A. Interestingly, neurons are 
known to bear a HeSPG on their surfaces (33), and interac- 
tions between HeS and N-CAM appear to influence the ho- 
mophillic binding of N-CAM during neuron-neuron adhe- 
sion (10, 11). During the outgrowth of  processes, it is possible 
that neurons form their own HeSPG-laminin association by 
displacing the HeS in the complex with their own HeS moi- 
ety, thereby promoting neuritic extension.  The binding of 
INO may prevent this neuron-matrix association and so cur- 
tail outgrowth. Thus, HeSPG on cell surfaces may regulate 
interactions between neurons and the environment. 
Some investigators have proposed that the inability of anti- 
laminin to block regeneration stimulated by the complex can 
be explained by species and tissue differences in laminin iso- 
forms.  Most  investigators  use  laminin  purified  from the 
mouse Englebreth-Holm-Swarm sarcoma, and anti-laminin 
antisera is most commonly generated using this form oflami- 
nin as the immunogen. While it is likely that rat and mouse 
laminin share a fair degree of homology, it is still possible 
that sufficient heterogeneity exists at the neurite-promoting 
site such that antibodies to mouse laminin are unable to block 
the activity of rat laminin.  However, antibodies generated 
against rat yolk sac laminin block neurite promotion by both 
rat and mouse laminin, yet proved inadequate in preventing 
the action of the proteoglycan-laminin factor secreted by rat 
Schwannomas (31). Results such as these have led to the sug- 
gestion that different tissues may produce different forms of 
laminin, even within the same species. Indirect support for 
this idea comes from immunofluorescence studies showing 
non-identical distribution of different laminin epitopes with- 
in the same animal (20, 47). Nevertheless, it appears improb- 
able that while laminin from mouse Englebreth-Holm-Swarm 
sarcoma and rat yolk sac bear similar bioactive sites,  the 
outgrowth-promoting active site on laminin produced by a 
rat cell line would be radically different. A more likely expla- 
nation may be that the regeneration-promoting active site on 
the rat Schwannoma complex is not recognized by or is not 
accessible  to  blocking  antibodies  which  only  recognize 
laminin. 
Comparative immunofluorescence studies with INO and 
Chiu et al. Neurite Regeneration Blocking Activity  1391 The Journal of Cell Biology, Volume 103, 1986  1392 Figure 9. Immunoreactivity for INO and for Po ends at the transitional zone between the PNS and the CNS. In sections of spinal cord 
where the CNS protrudes, dome-like (asterisk)  into the proximal end of the dorsal root, double-labeling  with INO (e) and with anti-Po 
(f) shows that binding  sites for both antibodies end abruptly at the transitional  zone. A consecutive section (a-c), which was double-labeled 
with INO (b) and with propidium iodide (c) to localize nuclei, shows that INO stains nuclei, presumably of neurons in the dorsal horn 
(arrowhead) while glial nuclei (arrow)  present outside of the horn area are not immunoreactive. The dome-shaped transitional zone also 
bears few stained nuclei. Phase micrograph of the field in b and c is shown in a, and of e and f  in d. Bar,  100 gin. 
Figure 8.  Immunofluorescent  demonstration of the presence of the INO, laminin, and HeSPG antigens in the PNS but not in the CNS. 
10-gin sections of adult rat spinal cord show only ventral roots stained positively with monoclonal antibodies INO (a), C21 (b), C24 (c), 
and C17 (d); e-h are the phase micrographs  of the fields seen in a-d, respectively. In the ventral root, all four antibodies bind specifically 
to the endoneurium surrounding axons, and in each case, staining is continuous with short fingers of the PNS that project into the spinal 
cord (arrows). However, except for blood vessels, staining is absent within the CNS proper. INO (a) alone also stained nuclei (presumably 
neuronal, see Fig.  10) within the spinal cord.  Fields in a and b axe taken from consecutive sections.  Bar, 50 ltm. 
Chiu et al. Neurite Regeneration  Blocking Activity  1393 Figure 10.  INO binds to the surfaces of several types of rat muscles including (a) cardiac (C) and skeletal (S) muscles, and (b) muscle 
spindles. INO immunoreactivity  persists in empty basement membrane sheathes after muscle fibers were damaged and removed by phagocy- 
tosis (c). This section is double-labeled with rabbit anti-laminin and INO; INO-positive  profiles co-localize with anti-laminin staining (d). 
At the neuromuscular junction, INO binding (e) is also present at postsynaptic sites concomittantly marked by rhodamine-a-bungarotoxin 
(f). In a control section, no immunoreactivity is seen when primary antibody was omitted (g); the endplate in this section is again marked 
by rhodamine-a-bungarotoxin (h).  Magnification is identical for b-h; bars, 50 tim. 
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to basement membranes  that  also  bear both laminin and 
HeSPG. This observation is consistent with the biochemical 
evidence that INO binding requires the presence of these two 
matrix molecules. Thus in vivo, as in vitro, the INO-binding 
site colocalizes with laminin and HeSPG in the extracellular 
matrix. 
In situ localization of the INO epitope also shows that it 
is consistently found in locations known to support neuronal 
regeneration. Thus INO binding is detectable throughout the 
PNS, in the basal lamina of both myelinating and nonmye- 
linating Schwann cells; immunoreactivity is present where 
the PNS begins, in the transitional region in spinal roots, and 
extends to the most distal reaches of the periphery, including 
the terminal arbors of motorneurons. In marked contrast, no 
cell  surface  INO  binding  is  seen  in  the  adult  rat  CNS. 
Numerous studies have documented the ability of neurons to 
regenerate in the PNS after damage;  new processes often 
grow long distances to re-establish synaptic contacts with 
target  cells.  Such  extensive regeneration does  not  occur 
within the CNS where neurite outgrowth is soon aborted. 
This inability to regenerate is not intrinsic to neurons of the 
CNS, rather the extracellular milieu of the PNS appears to 
be much more supportive of axonal growth. CNS neurons 
can regenerate relatively long distances into a graft of  periph- 
eral nerve in vivo (5), or when provided with a suitable sub- 
strate in vitro (29,  31, 39). The segregation of the INO epi- 
tope in the rat nervous system suggests that one component 
of the environment that facilitates axonal outgrowth, namely 
a  neurite-promoting extracellular matrix,  is  absent in the 
CNS, and may be a key reason for the inability of neurons 
to regenerate in the CNS. 
It is also well known that denervated target cells provide 
signals that promote neuronal sprouting, even by uninjured 
neighboring axons (7, 13, 37).  Such signaling can occur via 
several means. For example, diffusible sprouting factors may 
Table IV. Basement Membrane Staining 
be released (21) and cell surface molecules that render the 
targetattractive to neurons may be produced (15). Our obser- 
vation that the INO epitope is dramatically increased in the 
basement membrane surrounding muscles after denervation 
suggests a third means of promoting sprouting. Thus target 
cells may use several mechanisms simultaneously to attract 
neurons  and  hasten  reinnervation.  In  denervated muscle, 
there is no apparent change in laminin;  however, the rise 
in  INO  binding  is  accompanied by a  detectable increase 
in HeSPG immunoreactivity. Furthermore, the intensity of 
staining by both INO and C17 increases with duration of 
denervation.  Since  the  biochemical  evidence  indicates 
that INO binding requires both HeSPG and laminin, these 
observations suggest that in muscle basement membrane, the 
level of the  INO  epitope is  limited by the  availability of 
HeSPG. 
In summary, our reassociation studies show that formation 
of the HeSPG-laminin complex generates a new epitope, the 
INO-binding site, which plays an important role in neurite 
regeneration. Several lines of evidence support the signifi- 
cance of this epitope, and thus the whole complex, in neu- 
ronal regeneration:  (a) INO,  a  monospecific reagent,  can 
both precipitate and, more importantly, block the activity of 
the entire complex. (b) The INO epitope is localized both in 
the nervous system and in target tissues, at sites known to 
support or enhance axonal regeneration, but is not detected 
in areas where neurons do not normally regenerate or tra- 
verse. Laminin, on the other hand, has a much more wide- 
spread distribution; for example, it is abundantly expressed 
in the basement membrane-rich kidney where axons do not 
normally ramify. (c) In experiments designed to mimic the 
physiological substrates for regeneration, INO inhibits neu- 
ronal  outgrowth on frozen sections  of peripheral  nerves, 
whereas anti-laminin does not (40). These results argue that 
the physiological substrate upon which axonal regeneration 
normally occurs is the HeSPG-laminin complex. 
C17 (HeSPG)  C24 (Laminin)  C21  (Laminin)  Laminin antisera  INO 
Adrenal 
Cortex  +++  .... 
Medulla  +++  +++  +++  +++  ++ 
Kidney 
Tubules  * -  ++  ++  ++  - 
Glomerular  capsule  ++  +/-  -  -  ++ 
Glomerular  matrix  ++  ++  -  -  _ 
Large blood vessels  +++  +++  -  +  - 
Skeletal  muscle  endomysium 
Extrasynaptic  +++  +++  +++  +++  ++ 
Synaptic  +++  +++  -  +++  ++ 
Myotendinous  junction  +++  +++  -  +++  ++ 
Intramuscular  nerve 
Perineurium  +++  +++  -  +++  +++ 
Endoneurium  +++  +++  +++  +++  ++ 
Sciatic nerve and peripheral ganglia 
Epineurium  +++  +++  -  +++  - 
Perineurium  +++  +++  -  +++  ++ 
Endoneurium  +++  +++  +++  +++  ++ 
Intensity of immunofluorescent staining range from extremely bright (+++),  bright (++),  faint (+), to undetectable (-). 
* In other studies (18, 42),  C17 has been known to stain tubules in frozen sections of Sprague-Dawley rat kidneys. 
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